Literature DB >> 12113490

The changing epidemiological pattern of hepatitis A in England and Wales.

M C Morris1, N J Gay, L M Hesketh, P Morgan-Capner, E Miller.   

Abstract

Sera from an age-stratified sample of 4188 individuals, submitted for diagnostic purposes to 15 public health laboratories in England and Wales in 1996, were tested for hepatitis A antibody. The serological profiles were consistent with declining incidence in the past. This hypothesis was tested by comparing the serological profiles of Ashford, Leeds and Preston public health laboratories with those from sera collected during a previous study in the same laboratories in 1986/7. A comparison of equivalent 10 year birth cohorts revealed that significant hepatitis A seroconversion had only continued in Ashford. However, it is probable that most seroconversions are due to vaccination and immigration rather than continuing viral transmission. Further population-based surveys collecting more in-depth social and demographic data are needed to confirm the main factors influencing hepatitis A seroprevalence and to explain the regional differences.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12113490      PMCID: PMC2869842          DOI: 10.1017/s095026880200701x

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  6 in total

1.  Hepatitis A surveillance in England--how many cases are not reported and does it really matter?

Authors:  N Matin; A Grant; J Granerod; N Crowcroft
Journal:  Epidemiol Infect       Date:  2006-05-10       Impact factor: 2.451

2.  Hepatitis A virus infection in people of South Asian origin in England and Wales: analysis of laboratory reports between 1992 and 2004.

Authors:  U Gungabissoon; N Andrews; N S Crowcroft
Journal:  Epidemiol Infect       Date:  2006-09-26       Impact factor: 2.451

3.  A population-based prevalence study of hepatitis A, B and C virus using oral fluid in Flanders, Belgium.

Authors:  Sophie Quoilin; Veronik Hutse; Hans Vandenberghe; Françoise Claeys; Els Verhaegen; Liesbet De Cock; Frank Van Loock; Geert Top; Pierre Van Damme; Robert Vranckx; Herman Van Oyen
Journal:  Eur J Epidemiol       Date:  2007-03-14       Impact factor: 8.082

4.  Protecting contacts of hepatitis A: what's the difference between vaccine and human normal immunoglobulin?

Authors:  N S Crowcroft
Journal:  Epidemiol Infect       Date:  2008-01       Impact factor: 2.451

Review 5.  Passive immunization for the public health control of communicable diseases: current status in four high-income countries and where to next.

Authors:  Megan K Young; Allan W Cripps
Journal:  Hum Vaccin Immunother       Date:  2013-06-19       Impact factor: 3.452

6.  Seroepidemiology of hepatitis a in the croatian population.

Authors:  Tatjana Vilibic-Cavlek; Jasmina Kucinar; Suncanica Ljubin-Sternak; Branko Kolaric
Journal:  Hepat Mon       Date:  2011-12-20       Impact factor: 0.660

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.